Skip Navigation


International Immunology Advance Access originally published online on November 22, 2004
International Immunology 2005 17(1):35-44; doi:10.1093/intimm/dxh183
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/1/35    most recent
dxh183v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gunnlaugsdottir, B.
Right arrow Articles by Ludviksson, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunnlaugsdottir, B.
Right arrow Articles by Ludviksson, B. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2005 The Japanese Society for Immunology

Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-ß1 on CD4+ and CD8+ naïve human T-cells

Brynja Gunnlaugsdottir1,2, Solrun M. Maggadottir1,2,3 and Björn R. Ludviksson1,2,3

1 Center for Rheumatology Research and 2 Institute for Medical Laboratory Sciences, Department of Immunology, Landspitali-University Hospital and 3 Department of Medicine, National University of Iceland, Reykjavik, Iceland

Correspondence to: B. R. Ludviksson; E-mail: bjornlud{at}landspitali.is

TGF-ß1 is a powerful regulator of various T-cell functions. However, it has been unclear how the T-cell responsiveness towards TGF-ß1 is affected by its phenotype or signaling intensity. In the present study, we demonstrate that the phenotype and the TCR-signaling intensity of the responding T-cell as well as the presence of anti-CD28 co-stimulation markedly affects how naïve human cord blood T-cells respond to TGF-ß1. In this report we demonstrate that the strength of the stimulatory signal modifies the T-cell response towards TGF-ß1. Thus, the greatest anti-proliferative effect of TGF-ß1 was observed during weak stimulatory conditions (low dose of anti-CD3 with no co-stimulatory signal). However, such anti-proliferative effect was reduced during strong stimulatory signal (high dose of anti-CD3 with a CD28-directed co-stimulatory signal). In addition, our results indicate that CD8+ T-cells are generally more responsive towards TGF-ß1 than CD4+ T-cells. To our surprise, naïve T-cells had a skewed Th1/Tc1 cytokine secretion pattern with high amounts of IL-2, IFN{gamma} and TNF{alpha}, but low amounts of IL-4, IL-5 and IL-10. TGFß1 significantly reduced the secretion of IL-2 and IFN{gamma}, but such suppression was partially prevented by anti-CD28-induced co-stimulation. In contrast, the inhibitory effect on IL-5 secretion was unaffected by anti-CD28 co-stimulation. Interestingly, TGF-ß1 induced IL-10 and TNF{alpha} secretion. However, the induction of IL-10 secretion was reduced during optimal stimulatory conditions while TGF-ß1 further induced TNF{alpha} secretion. These data demonstrate that the duration, intensity and type of signaling alters the sensitivity of T-cells to powerful immunological modifying agents like TGF-ß1.

Keywords: TGF-ß1, T Lymphocytes, cellular proliferation, costimulation, anergy

Transmitting editor: W. Strober


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Koehler, D. Kofler, A. Hombach, and H. Abken
CD28 Costimulation Overcomes Transforming Growth Factor-{beta}-Mediated Repression of Proliferation of Redirected Human CD4+ and CD8+ T Cells in an Antitumor Cell Attack
Cancer Res., March 1, 2007; 67(5): 2265 - 2273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-L. Ling, N. Dulphy, P. Bahl, M. Salio, K. Maskell, J. Piris, B. F. Warren, B. D. George, N. J. Mortensen, and V. Cerundolo
Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL
J. Immunol., March 1, 2007; 178(5): 2908 - 2915.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.